Cite
MLA Citation
T Hisamatsu et al.. “DOP32 Withdrawal of thiopurines in Crohn's disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2).” Journal of Crohn's and colitis, vol. 13, n.d., pp. S043–S044. http://access.bl.uk/ark:/81055/vdc_100092354186.0x00000b